Overall, our findings further demonstrate the clinical relevance of AR/AR-SVs to HCC and their role in upregulating pro-oncogenic pathways such as E2F targets, G2/M checkpoints, Myc, and mitotic spindles. The gene discussed is AR; the disease is hepatocellular carcinoma.